This brand name is authorized in Nigeria.
The drug CAL D3 PLUS contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
H0G9379FGK - CALCIUM CARBONATE
|
Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement. |
|
2
|
UNII
1C6V77QF41 - CHOLECALCIFEROL
|
In its biologically active form vitamin D3 stimulates intestinal calcium absorption, incorporation of calcium into the osteoid, and release of calcium from bone tissue. In the small intestine it promotes rapid and delayed calcium uptake. The passive and active transport of phosphate is also stimulated. |
|
3
|
UNII
3A3U0GI71G - MAGNESIUM OXIDE
|
Magnesium oxide (MgO), or magnesia, is an empirical formula of MgO and consists of a lattice of Mg2+ ions and O2− ions held together by ionic bonding. |
|
4
|
UNII
PTX099XSF1 - ZINC SULFATE MONOHYDRATE
|
Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
B4-0665 | Tablet | CALD3 PLUS TABLET TAB 500 mg; 200 IU; 100 mg; 7.5 mg 2X15 | 90 RNW-PP-236930 CALD3 PLUS TABLET CALCIUM CARBONATE EACH TABLET CONTAINS; CALCIUM CARBONATE 500MG, VITAMIN D3 200IU, MAGNESIUM OXIDE 100MG, ZINC SULPHATE MONOHYDRATE 7.5MG, EXCIPIENTS Q.S MAIZE STARCH BP 52MG GELATIN BP 10MG METHYL HYDROXYBENZOATE BP 1.4MG PROPYL HYDROXYBENZOATE BP 0.2MG PURIFIED WATER BP Q.S B4-0665 Drugs Imported Products 2X15 Prescription Only Medicine (POM) 11/3/2021 EMBASSY PHARMACEUTICAL AND CHEMICALS LIMITED, 41,ADEMOLA STREET S.W IKOYI 14630021 grasol2010@yahoo.com M/S LABORATE PHARMACEUTICAL (INDIA),, E-11, IND. AREA PANIPAT HARYANA ( INDIA)., India | 25/05/2023 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | B4-0665 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.